Calton & Associates’s Eastman Chemical EMN Stock Holding History

Calton & Associates’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25	Closed	-$2K	–	596
2017 Q4	$2K	Buy	+25	New	+$2.27K	﹤0.01%	1390

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Calton & Associates's EMN Position: Q1 2018 in Review

Calton & Associates sold out of Eastman Chemical (EMN) in Q1 2018, closing a stake of 25 shares — an estimated $2K sold.

Calton & Associates first reported a position in EMN in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 703 funds tracked by Wall St. Rank hold EMN as of Q1 2018.

Calton & Associates reported no remaining Eastman Chemical position as of Q1 2018 after selling out during the quarter.
Calton & Associates sold 25 Eastman Chemical shares in Q1 2018, an estimated $2K.
Calton & Associates first reported a position in Eastman Chemical in Q4 2017 and held it in 1 quarter.
Calton & Associates's Eastman Chemical position peaked at $2K in Q4 2017.
703 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.